Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
MEQ.TO 2.81TRI.TO -1.04KKR -0.16CGI.TO -0.01KINS 0.36MAL.TO 0.57NOW -0.44NBIS 5.78
Daily Stock Opinions and Ratings
Stockchase Opinions

Glenn Paradis, BA, CFABiomiraBRA.TOSTRONG BUYOct 13, 2000

Undervalued. Market waiting for a partner & test results. Should be there by year end
Glenn Paradis, BA, CFAGlenn Paradis, BA, CFA
Unknown
Unlock Rating
$14.00

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist
Track your Stocks in your Watch List

You might be interested:

SELL

Biomira(BRA.TO)

Dec 03, 2004
Not a fan of biotech stocks. Difficult to read with all the little points of approval or non-approval. With the big spike, don't buy.
Photo of David ChapmanDavid Chapman
No
Unlock Rating
$3.88

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Biomira(BRA.TO)

Apr 23, 2004
The entire energy sector is an interesting play. There has been a shrinkage of capacity in the last several years.
Photo of Alison DeansAlison Deans
Owned
Unlock Rating
$67.58

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Biomira(BRA.TO)

Jan 16, 2003
Outlook is anybody's guess. No earnings.
Photo of Ross HealyRoss HealyUnlock Rating
$1.85

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Biomira(BRA.TO)

Jan 16, 2002
Will take a while. Prefers Isotechnica,
Photo of Ray SteeleRay SteeleUnlock Rating
$6.28

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Biomira(BRA.TO)

Dec 28, 2001
RISKY. No earnings. Treat as a trading stock between $5 and $7.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$6.75

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Biomira(BRA.TO)

Nov 14, 2001
Good long term investment, but prefers MDS.
Photo of Peter BriegerPeter BriegerUnlock Rating
$7.00

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Biomira(BRA.TO)

Oct 31, 2001
Great product, but company has had problems.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$6.00

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Biomira(BRA.TO)

Sep 19, 2001
Biotechs out of favour. Has broken $6.40. Next level is $3.90.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$6.30

Stock price when the opinion was issued

biotechnologypharmaceutical
WAIT

Biomira(BRA.TO)

May 25, 2001
Taking a long time to get to market.
Photo of John ZechnerJohn ZechnerUnlock Rating
$12.64

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Biomira(BRA.TO)

May 18, 2001
Doesn't have top line growth. Some products in 3rd phase. Speculative.
Photo of John ZechnerJohn ZechnerUnlock Rating
$11.08

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Biomira(BRA.TO)

May 04, 2001
In phase 3 and has partnered with Merk.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$12.96

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Biomira(BRA.TO)

Apr 09, 2001
Smart mngmnt. Good sector. Big litigation risk re: patents/class action suits in pharmaceuticals.
Photo of David BaskinDavid BaskinUnlock Rating
$10.38

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Biomira(BRA.TO)

Feb 01, 2001
Good company. Drugs in 3rd phase. Short term should do well. Getting a new partner
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$12.40

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Biomira(BRA.TO)

Jan 23, 2001
A very active/volatile stock. Lots of press
Photo of Steven MisenerSteven MisenerUnlock Rating
$12.85

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Biomira(BRA.TO)

Nov 21, 2000
Difficult to select which bio company but prefers BioChem or a fund
Photo of Fred KetchenFred KetchenUnlock Rating
$13.00

Stock price when the opinion was issued

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

V -3.14$327.24
RCI.B.TO 0.66$53.16
BIP.UN.T… 0.25$53.06
GOOG 5.36$367.46
DSG.TO -4.01$95.17

Today's Top Picks

MEQ.TO 2.81$169.25
TRI.TO -1.04$111.02
KKR -0.16$97.01
CGI.TO -0.01$52.69
KINS 0.36$16.25

Popular Articles

Latest Sell Signals

DOL.TO -1.28$187.85
CTC.A.TO 0.59$186.64
CCO.TO 1.16$150.46
CAT 29.9$985.82
EQB.TO 2.09$124.69

Most Recent Experts

Chris Blumas

Chris Blumas

at Raymond James Investment Counsel Ltd.

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

John Zechner

John Zechner

J. Zechner & Assoc

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica